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VC is currently at Medtronic in Jacksonvilla b s t r a c t
Hip implants containing cobalt–chromium (CoCr) have been used for
over 80 years. In patients with metal-on-metal (MoM) hip implants,
it has been suggested that wear debris particles may contribute to
metal sensitization in some individuals, leading to adverse reactions.
This article presents data from a study in which the popliteal lymph
node assay (PLNA) was used to assess immune responses in mice
treated with chromium-oxide (Cr2O3) particles, metal salts (CoCl2,
CrCl3, and NiCl2) or Cr2O3 particles with metal salts (“A preliminary
evaluation of immune stimulation following exposure to metal
particles and ions using the mouse popliteal lymph node assay” (B.E.
Tvermoes, K.M. Unice, B. Winans, M. Kovochich, E.S. Fung, W.V.
Christian, E. Donovan, B.L. Finley, B.L. Kimber, I. Kimber, D.J. Paus-
tenbach, 2016) [1]). Data are presented on (1) the chemical char-
acterization of TiO2 particles (used as a particle control), (2) clinical
observations in mice treated with Cr2O3 particles, metal salts or
Cr2O3 particles with metal salts, (3) PLN weight and weight index
(WI) in mice treated with Cr2O3 particles, metal salts or Cr2O3vier Inc. This is an open access article under the CC BY license
/j.taap.2016.07.020
B.E. Tvermoes).
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B. Winans et al. / Data in Brief 9 (2016) 388–397 389particles with metal salts, (4) histological changes in PLNs of mice
treated with Cr2O3 particles, metal salts or Cr2O3 particles with metal
salts, (5) percentages of immune cells in the PLNs of mice treated
with Cr2O3 particles, metal salts or Cr2O3 particles with metal salts,
and (6) percentages of proliferating cells in the PLNs of mice treated
with Cr2O3 particles, metal salts or Cr2O3 particles with metal salts.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaToxicology, Popliteal Lymph Node Assay, Metal-on-Metal Hip Implants, Histol-
ogy, Metal Sensitization, Immune Stimulationype of data Tables, ﬁgures
ow data was
acquiredObservation, Microscope and Hemocytometer, Scanning Electron Microscope
(Hitachi S5500), Electron Dispersive Spectroscope, Flow Cytometer (BD
FacsScan)ata format Analyzed
xperimental
factorsBALB/c mice were given a single footpad injection of Cr2O3 particles, metal salts
(CoCl2, CrCl3, and NiCl2), Cr2O3 particles plus metal salts, or controls. Four to 11
days later the immune response in the popliteal lymph node (PLN) was assessed.xperimental
featuresFour to 11 days following the footpad injection of Cr2O3 particles, metal salts
(CoCl2, CrCl3, and NiCl2), Cr2O3 particles plus metal salts, or controls, clinical
observations and the weight and weight index of the PLN were assessed. Flow
cytometry was performed to evaluate the proportion of various immune cells
and proliferation of cells in the PLN following treatment with the test articles.
Additionally, histology was performed on the PLNs of treated mice.ata source
locationMB Labs, Spinnerstown, PA; Calvert Labs, Scott Township, PA; and RJ Lee Group,
Monroeville, PAata accessibility With this articleValue of the data
 These data represent the ﬁrst use of the PLNA to test the immune response in mice treated with
Cr2O3 particles, and will be of value to researchers studying metal sensitization.
 Histological parameters, including development of germinal centers and hyperplasia of lymphocytes
in the cortex, are presented for mice treated with the test articles. These data will be of value in trying
to understand the type of immune response observed following treatment with metal particles and
ions and to researchers evaluating PLN histology following treatment with metals or other agents.
 Flow cytometry was performed, evaluating the response of various types of immune cells,
including B220þ , CD3þ , CD4þ , CD8þ , I-ADþ and CD69þ cells. These data will be of value in trying
to fully characterize the type of immune response observed following treatment with metal
particles and ions and to researchers evaluating changes in the percentage of immune cells in the
PLN following treatment with metals or other agents.
 PLN weight, ﬂow cytometry and histology endpoints were all evaluated in the same treatment groups,
allowing comparison across multiple endpoints to better assess the immune response. These data will be
of value to researchers evaluating the immune response following treatment with metals or other agents.
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This data in brief article contains data on the induced immune response in the popliteal lymph
node (PLN) of mice treated with Cr2O3 particles and/or metal salts from two experiments. From the
ﬁrst experiment, the following data are presented: compositional analysis of TiO2 particles (Supple-
mentary Fig. 1); evaluation of localized inﬂammation (Supplementary Table 1) and discoloration
(Supplementary Table 2) in the footpad; mean footpad swelling (Supplementary Fig. 2); mean change
in body weight (Supplementary Fig. 3); mean PLN weight (Fig. 1); histological evaluation of the PLN
(Tables 1–4); and representative ﬂow cytometry plots for the percentage of cells positive for CD3 and
B220 (Supplementary Fig. 4, 5), I-AD and CD69 (Supplementary Fig. 6, 7), CD4 and CD8 (Supple-
mentary Fig. 8, 9) and BrdU (Supplementary Fig. 10, 11). From the second experiment, the following
data are presented: evaluation of localized inﬂammation (Supplementary Table 3) and discoloration
(Supplementary Table 4) in the footpad; mean footpad swelling (Supplementary Fig. 12); mean
change in body weight (Supplementary Fig. 13); and mean PLN weight (Fig. 2) and WI (Fig. 3). Please
refer to [1] for related data and interpretations.2. Experimental design, materials and methods
The materials and methods have been described previously [1]. Brieﬂy, the materials and methods
were as follows:2.1. Animals
Nulliparous, experimentally naïve, 6–8 week old female BALB/c mice (Charles River Laboratories)
were housed in metal-free, disposable plastic cages. The mice were maintained on a 12-hour light/
dark cycle in a temperature-controlled environment, and were acclimatized for at least ﬁve days.
Distilled water and rodent chow were provided ad libitum. All procedures complied with acceptable
standards of animal welfare and humane care by the Institutional Animal Care and Use Committee
(IACUC) of MB Research (Spinnerstown, PA) and Calvert Labs (Scott Township, PA).ig. 1. PLN weight four days following footpad injection in Experiment 1. Mice either received no injection (sham), or were
njected with a vehicle control or test article as indicated. Four days after treatment, mice were sacriﬁced and the ipsilateral
LN was weighed. Data are presented as the meanþSE.
Table 2
Histology of the PLN of positive and negative chemical controls in Experiment 1. Four days following sham injection or injection
of vehicle controls, the indicated histological parameters were evaluated in the PLN.
Parameter Treatment Group
DNCB
0.125 mg
DNCB
0.3 mg
SDS
0.0938 mg
DCNB
0.125 mg
DCNB
0.3 mg
Animal #
409 410 279 280 269 270 419 420 429 430
Number of secondary follicles/germinal centersa þþ      þ þ  
Number of primary folliclesb þþþ þþ þ þþþ þþ þþ þ þþþ þþ þþ
Maturity of lymphocytes in cortexc þþ þ þ þ þ þ þ þþ þ þ
Lymphocyte hyperplasia in paracortexd þ þþ  þþ  þ þ þ  þþ
Presence of plasma cells in medullary cordse          
Necrosisf          
Acute inﬂammation: Edemag          
Acute inﬂammation: Polymorphonuclear cellsh        þ  
a :  ¼ absent, þ ¼1–2 follicles, þþ ¼3–4 follicles.
b :  ¼ no cortex present on sample, þ ¼1–2 follicles, þþ ¼3–4 follicles, þþþ ¼5–6 follicles, þþþþ ¼7–8 folli-
cles.
c : þ ¼all small lymphocytes, þþ ¼5% immature lymphocytes, þþþ ¼10% immature lymphocytes.
d :  ¼ absent, þ ¼minimal size, mature lymphocytes, þþ ¼medium size, 5% immature lymphocytes, þþþ ¼ large
size, 10% immature lymphocytes, þþþþ ¼extra-large size, 20% immature lymphocytes.
e :  ¼ none observed, þ ¼several, þþ ¼readily apparent, þþþ ¼cords ﬁlled.
f : ¼ absent, þ ¼minimal foci.
g :  ¼ absent, þ ¼ minimal foci.
h :  ¼ absent, þ ¼ minimal foci.
Table 1
Histology of the PLN of sham control and vehicle controls in Experiment 1. Four days following sham injection or injection of
vehicle controls, the indicated histological parameters were evaluated in the PLN.
Parameter Treatment Group
Sham 20% DMSO-
A
20% DMSO-
B
Serum:PBS-
A
Serum:PBS-
B
Animal #
389 390 259 260 399 400 319 320 469 470
Number of secondary follicles/germinal centersa      NAb    
Number of primary folliclesc þþþþ þþ þþ þþþ þþ NA þþ þþ þþ þþ
Maturity of lymphocytes in cortexd þ þ þ þ þ NA þ þ þ þ
Lymphocyte hyperplasia in paracortexe þþ þ þ þ þ NA þ þ  þ
Presence of plasma cells in medullary cordsf      NA    
Necrosisg      NA    
Acute inﬂammation: Edemah      NA    
Acute inﬂammation: Polymorphonuclear cellsi      NA    
a :  ¼ absent, þ ¼1–2 follicles, þþ ¼3–4 follicles.
b : NA=tissue not available for analysis.
c :  = no cortex present on sample, + =1-2 follicles, ++ =3-4 follicles, +++ =5-6 follicles, ++++ =7-8 follicles.
d : + =all small lymphocytes, ++ =~5% immature lymphocytes, +++ =~10% immature lymphocytes.
e :  = absent, + =minimal size, mature lymphocytes, ++ =medium size, ~5% immature lymphocytes, +++ =large size,
~10% immature lymphocytes, ++++ =extra-large size, ~20% immature lymphocytes.cords ﬁlled.
f :  = none observed, + =several, ++ =readily apparent, +++ =cords ﬁlled.
g := absent, + =minimal foci.
h : = absent, + = minimal foci.
i :  = absent, + = minimal foci.
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Table 3
Histology of the PLN of positive and negative metal controls in Experiment 1. Four days following sham injection or injection
of vehicle controls, the indicated histological parameters were evaluated in the PLN.
Parameter Treatment Group
AuCl3
0.0156 mg
AuCl3
0.0625 mg
AuCl3
0.125 mg
K2Cr2O7
0.00625 mg
K2Cr2O7
0.025 mg
K2Cr2O7
0.050 mg
TiO2
0.0210 mg
Animal #
439 440 449 450 459 460 289 290 299 300 309 310 479 480
Number of secondary
follicles/germinal
centersa
     þ   NAb NA    
Number of primary
folliclesc
þþ þþ þþ þþ þþþ þþ  þþ NA NA þþ þþþ þþþ þþ
Maturity of lympho-
cytes in cortexd
þ þ þ þþþ þ þþ  þ NA NA þ þ þþ þ
Lymphocyte hyper-
plasia in paracortexe
þ þ þþ þþ þþ þþ  þ NA NA þþþþ þþþþ þ 
Presence of plasma
cells in medullary
cordsf
        NA NA    
Necrosisg         NA NA    
Acute inﬂammation:
Edemah
        NA NA    
Acute inﬂammation:
Polymorphonuclear
cellsi
        NA NA    
a :  ¼ absent, þ ¼1–2 follicles, þþ ¼3–4 follicles.
b : NA=tissue not available for analysis.
c :  = no cortex present on sample, + =1-2 follicles, ++ =3-4 follicles, +++ =5-6 follicles, ++++ =7-8 follicles.
d : + =all small lymphocytes, ++ =~5% immature lymphocytes, +++ =~10% immature lymphocytes.
e :  = absent, + =minimal size, mature lymphocytes, ++ =medium size, ~5% immature lymphocytes, +++ =large size,
~10% immature lymphocytes, ++++ =extra-large size, ~20% immature lymphocytes.
f :  = none observed, + =several, ++ =readily apparent, +++ =cords ﬁlled.
g : = absent, + =minimal foci.
h : = absent, + = minimal foci.
i : = absent, + = minimal foci.
B. Winans et al. / Data in Brief 9 (2016) 388–3973922.2. Chemicals and reagents
The following reagents were purchased from the source listed in Table 5.2.3. Characterization of metallic particles
The morphology of the TiO2 particles was determined using a Hitachi S5500 Ultra-high Resolution
Scanning Electron Microscope at an accelerating voltage of 2.0 kV with secondary electron contrast at
RJ Lee Group (Monroeville, PA). Composition of the TiO2 particles was determined using a Bruker
energy dispersive spectroscopy (EDS) detector at an accelerating voltage of 20 kV.2.4. PLNA
Mice were anesthetized with isoﬂurane and injected subcutaneously with 50 μL of vehicle or test
article into the right hind footpad. The dosing groups are presented in Table 6.
All dilutions were prepared fresh daily and were stirred or vortexed until homogeneous. Dilutions
were vortexed prior to dosing each mouse. Treatment doses were based on previous literature and
Table 4
Histology of the PLN of treatment groups in Experiment 1. Four days following sham injection or injection of vehicle controls, the indicated histological parameters were evaluated in
the PLN.
Parameter Treatment Group
Cr2O3
0.0144E-3 mg
Cr2O3
0.0101 mg
Cr2O3
0.0216 mg
Metal Salts
0.0998E-3 mg
Metal Salts
0.0699 mg
Metal
Salts
0.150 mg
Cr2O3þMetal
Salts
0.114E-3 mg
Cr2O3þMetal
Salts
0.0800 mg
Cr2O3þMetal
Salts
0.171 mg
Animal #
489 490 499 500 379 380 509 510 369 370 359 360 329 330 339 340 349 350
Number of secondary follicles/germinal
centersa
þþ     þ þ þ   þ       þþ
Number of primary folliclesb þþþ þþþ þþþþ þþþ þþ þþþ þ þþþþ þþþ þþ þþ þ þþ þ þþ þþ þþ þþþ
Maturity of lymphocytes in cortexc þþ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þþ
Lymphocyte hyperplasia in paracortexd þ þþ þþ þþ þ þþ  þþ þ  þþ þ þ þ þ þþ þþ þþþ
Presence of plasma cells in medullary
cordse
                 
Necrosisf                  
Acute inﬂammation: Edemag                  
Acute inﬂammation: Polymorpho-
nuclear cellsh
         þ        
a :  ¼ absent, þ ¼1–2 follicles, þþ ¼3–4 follicles.
b :  ¼ no cortex present on sample, þ ¼1–2 follicles, þþ ¼3–4 follicles, þþþ ¼5–6 follicles, þþþþ ¼7–8 follicles.
c : þ ¼all small lymphocytes, þþ ¼5% immature lymphocytes, þþþ ¼10% immature lymphocytes.
d :  ¼ absent, þ ¼minimal size, mature lymphocytes, þþ ¼medium size, 5% immature lymphocytes, þþþ ¼ large size, 10% immature lymphocytes, þþþþ ¼extra-large
size, 20% immature lymphocytes.
e : ¼ none observed, þ ¼several, þþ ¼readily apparent, þþþ ¼cords ﬁlled.
f :  ¼ absent, þ ¼minimal foci.
g : ¼ absent, þ ¼ minimal foci.
h :  ¼ absent, þ ¼ minimal foci.
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Fig. 2. PLN weight 4, 7 and 11 days following footpad injection in Experiment 2. Mice were injected with a vehicle control or
test articles as indicated. On D4, D7, and D11, mice were sacriﬁced and the ipsilateral PLN was weighed. Note that no D4 data
were obtained for the 20% DMSO treatment group. Data are presented as the mean7SE.
Fig. 3. Weight index (WI) following footpad injections in Experiment 2. Mice were injected with vehicle controls or positive
controls (A) or test articles (B), as indicated. On D4, D7 and D11, PLN weight was recorded. The WI was calculated as follows:
PLN weight test animal / average PLN weight appropriate vehicle control. Note that no D4 data were obtained for the 20% DMSO
treatment group; therefore, WI values were not calculated for AuCl3 and K2Cr2O7 at D4. The dashed line indicates a WI value
of 2, which is the threshold value for a positive response in the PLNA. Data are presented as the mean7SE.
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Table 5
Reagents.
Reagent CAS # Source
Nickel chloride (NiCl26H2O) 7791-20-0 Sigma-Aldrich
Chromium chloride (CrCl36H2O) 10060-12-5 Sigma-Aldrich
Cobalt chloride (CoCl26H2O) 7791-13-1 Sigma-Aldrich
Chromium oxide particles (Cr2O3) 1308-38-9 Sigma-Aldrich
2,4-Dinitrochlorobenzene (DNCB) 97-00-7 Sigma-Aldrich
2,4-dichloronitrobenzene (DCNB) 611-06-3 Sigma-Aldrich
Sodium dodecyl sulfate (SDS) 151-21-3 Sigma-Aldrich
Bromodeoxyuridine (BrdU) NA Sigma-Aldrich
Dimethylsulfoxide (DMSO) NA Sigma-Aldrich
TiO2 particles (TiO2) 1317-70-0 US Research Nanomaterials, Inc
Potassium dichromate (K2Cr2O7) 7778-50-9 Fisher Scientiﬁc
Gold chloride (AuCl3) 13453-07-1 Acros Organics
Phosphate buffer saline (PBS) NA Hyclone
Syngeneic vehicle BALB/c mouse serum NA Charles River Laboratory
Flow cytometery antibodies NA BD Pharmingen or Acris Antibodies
B. Winans et al. / Data in Brief 9 (2016) 388–397 395dose-range ﬁnding studies [2–4]. See [1] for a detailed description of the rationale of dose
formulations.
2.5. Assessment of footpad swelling and general toxicity
The injection site of all animals was evaluated for signs of swelling or discoloration, and animals
were evaluated for distress or signs of general toxicity approximately four hours after injection and
once daily until sacriﬁce. Right hind footpad swelling was measured at 1, 2 and 4 days post injection
in Experiment 1 and from Day 0 to 11 in Experiment 2 using a digital micrometer. Body weights were
measured immediately prior to treatment on Day 0 and at sacriﬁce on Day 4, 7 or 11. Results for
footpad swelling and percent of initial body weight are expressed as mean7standard error (SE).
2.6. PLN weight and cell proliferation
In Experiment 1, ﬁve hours before sacriﬁce on Day 4, mice were administered bromodeoxyuridine
(BrdU) dissolved in PBS (3 mg per mouse; intraperitoneal). In Experiment 2, no BrdU was adminis-
tered. Mice were euthanized with carbon dioxide inhalation, and the ipsilateral PLNs were excised
from each mouse. PLNs were placed in PBS, adherent fatty tissue was removed, and PLNs were
weighed. Results for ipsilateral PLN weight and weight index (Experiment 2 only) are expressed as
mean7standard error (SE).
For each individual PLN, a single cell suspension was made by gentle disaggregation with a dis-
posable pestle, and cells were centrifuged, washed in PBS, and re-suspended in RPMI. In Experiment
1, the isolated LNCs were used for either determination of BrdU incorporation (ﬁxed in 75% EtOH and
stored up to one week at 20 °C) or for ﬂow cytometric analyses (stored overnight at 2–8 °C).
To determine BrdU incorporation in Experiment 1, cells were denatured with HCl Triton X Buffer
(1 N HCl, 0.5% Triton X) and neutralized by washing with borate buffer (pH 8.5). Nuclei were washed
with a staining buffer, incubated with BrdU-FITC (BD Biosciences, clone B44), washed again with
staining buffer and resuspended in PBS containing RNase A (Fisher Scientiﬁc) and propidium iodide
(PI, Sigma-Aldrich). Samples were incubated at room temperature for 30 min, and the percentage of
BrdUþ nuclei (i.e., percentage of proliferating lymphocytes in the PLN) was determined with a BD
FacScan
s
ﬂow cytometer.
2.7. Flow cytometry
In Experiment 1, PLN cells were incubated with either Rat IgG (for B220, CD3, CD4, and CD8) or
hamster/mouse IgG (for I-AD and CD69) for ten minutes to block non-speciﬁc binding. Approximately
Table 6
Treatment groups and doses used in Experiments 1 and 2.
Treatment group Vehicle Dose (mg) Number of mice for cellular
endpoints per timepoint
Number of mice for his-
tological endpoints.
Experiment 1
Vehicle control 20% DMSOa - - 16 4
Serum:PBSb - - 16 4
Chemical positive
control
DNCB 20%
DMSO
0.125
0.3
8
8
2
2
Chemical negative
control
SDS 20%
DMSO
0.0938 8 2
DCNB 20%
DMSO
0.125 8 2
0.3 8 2
Metal positive
control
AuCl3 20%
DMSO
0.0156 8 2
0.0625 8 2
0.125 8 2
K2Cr2O7 20%
DMSO
0.00625 8 2
0.025 8 2
0.050 8 2
Particle negative
control
TiO2 particles Serum:
PBS
0.0210 8 2
Cr2O3 particles and/
or metal saltsc,d
Cr2O3 particles Serum:
PBS
0.0000144 8 2
0.0101 8 2
0.0216 8 2
Metal Saltsc Serum:
PBS
0.0000998 8 2
0.0699 8 2
0.150 8 2
Cr2O3 particles þ
metal saltsc,d
Serum:
PBS
0.000114 8 2
0.0800 8 2
0.171 8 2
Experiment 2
Vehicle control 20% DMSOe - - 5e -
Serum:PBS - - 10 -
Metal positive
control
AuCl3 20%
DMSO
0.125 10 -
K2Cr2O7 20%
DMSO
0.025 10 -
Cr2O3 particles and/
or metal saltsc,d
Cr2O3 particles Serum:
PBS
0.0216 10 -
Cr2O3 particles þ
metal saltsc,d
Serum:
PBS
0.0005 10 -
0.0025 10 -
0.01 10 -
0.04 10 -
0.08 10 -
a In Experiment 1, there were two 20% DMSO groups (20% DMSO-A, 20% DMSO-B).
b In Experiment 1, there were two Serum:PBS groups (Serum:PBS-A, Serum:PBS-B).
c The ASTM F1537 standard speciﬁcations for wrought CoCr alloys used for surgical implants report that Co, Cr, and Ni
content comprise approximately 64%, 28%, and r1% of the implant alloy, respectively. The ratio of total individual metal salts
was based on these percentages, as discussed in [1].
d The ionic form of Co and Ni were administered. For Cr, a ratio of 62:38 particulate form (Cr2O3) to ionic form (Cr3þ) was
administered as discussed in [1].
e For the 20% DMSO group in Experiment 2, no mice were sacriﬁced at Day 4. At D7 and D11, 5 mice per group were
sacriﬁced.
B. Winans et al. / Data in Brief 9 (2016) 388–3973965x105 cells were incubated for 30–45 min on ice with ﬂuorescently-conjugated antibodies in the
following pairs: (1) B220-FITC (BD Pharmingen, clone RA3-6B2) and CD3-PE (BD Pharmingen, clone
17A2); (2) CD4-PE (BD Pharmingen, clone RM4-5) and CD8-FITC (BD Pharmingen, clone 53-6.7); or
(3) I-AD-FITC (Acris Antibodies, clone 34-5-3S) and CD69-PE (BD Pharmingen, clone H1.2F3). Cells
were ﬁxed with 70% ethanol and analyzed by ﬂow cytometry on a BD FacScan
s
ﬂow cytometer using
B. Winans et al. / Data in Brief 9 (2016) 388–397 39715 mW of power at 488 nm excitation wavelength. Data was acquired on BD CellQuest version
3.3 acquisition software, and CellQuest™ and FlowJo were used for data analysis.
2.8. Histology
For histological evaluation in Experiment 1 (n¼2 per treatment group), PLNs were ﬁxed in 10%
neutral-buffered formalin and embedded in parafﬁn. Tissues were cut to 5 μm thickness and stained
with hematoxylin and eosin (H&E). The pathologist evaluated the following parameters on a 0 to
4 scale: (1) number of primary follicles; (2) number of secondary follicles/germinal centers;
(3) maturity of lymphocytes in the cortex; (4) lymphocyte hyperplasia in the paracortex; (5) plasma
cells in the medullar cords; (6) necrosis; (7) acute inﬂammation (edema); and (8) acute inﬂammation
(inﬁltration of polymorphonuclear cells). The vehicle control groups were used to establish the
baseline scores, and the remaining groups were evaluated blinded as to treatment group.Acknowledgments
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